Revolutionizing Genome Editing with CRISPRIN MY OPINIONMark Behlke, CSO, Integrated DNA Technologies08LAST WORDSilji Abraham, Chief Digital and Transformation Officer, West Pharmaceutical [NYSE:WST]How Recent Technology Transformations in Pharma Analytics Impact Business3014INMUNOTEKPUSHING THE BOUNDARIES OF IMMUNOTHERAPY Jose L. Subiza, MD, PhD,President & CEO
< Page 3 | Page 5 >